课题基金 / 基金详情

Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma

Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma
NRF2高食管鳞癌的机制及靶向治疗
批准号:
10407469
负责人:
XIAOXIN Luke CHEN
金额:
$16.92万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-06-01 至 2022-12-31

项目摘要

项目成果

XIAOXIN Luke CHEN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This multiple-PI R01 proposal is designed to incorporate genetic and pharmacological approaches to understand the mechanisms of NRF2 hyperactivation in ESCC and to develop targeted therapy for Nrf2high ESCC. We believe Nrf2 and kinases are functionally interrelated, and thus cooperatively contribute to ESCC. In this proposal, we aim to characterize the molecular and phenotypic consequences of NRF2 hyperactivation in ESCC, determine the mechanisms of action and efficacy of NRF2 small molecule inhibitors in ESCC, and identify NRF2-responsive kinases and their functions in NRF2-driven ESCC biology. Through three independent yet tightly related Specific Aims, we will provide novel insights into pathway regulation and novel therapeutic targets/agents for NRF2high ESCC. If proven effective, some compounds may be further translated into the clinic for targeted therapy of NRF2high ESCC in the future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NRF2-ACSS2 Axis in Alcohol-induced Metabolic Reprogramming and Esophageal Pathology
NRF2-ACSS2 Axis in Alcohol-induced Metabolic Reprogramming and Esophageal Pathology
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma
  • 批准号:
    10530998
  • 项目类别:
  • 资助金额:
    $8.34万
  • 财政年份:
    2020
  • 负责人:
    XIAOXIN Luke CHEN
  • 依托单位:
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma
海外基金